956317-36-5

Basic information

• Product Name: 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID
• Synonyms: 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID;5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid;5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid (For suvorexant);Suvorexant Intermediate II;Benzoic acid, 5-methyl-2-(2H-1,2,3-triazol-2-yl)-;5-methyl-2-(triazol-2-yl)benzoic acid;5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic Acid;EOS-61935
• CAS NO: 956317-36-5
• Molecular Formula: C₁₀H₉N₃O₂
• Molecular Weight: 203.19736
• Mol File: 956317-36-5.mol
• Article Data: 62

Chemical Properties

• Melting Point: 174-176℃
• Boiling Point: 413℃
• Flash Point: 204℃
• Appearance: /
• Density: 1.35
• Vapor Pressure: 0-0.001Pa at 20-70℃
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: 3.00±0.36(Predicted)
• CAS DataBase Reference: 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID(956317-36-5)
• EPA Substance Registry System: 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID(956317-36-5)

Safety Data

• Hazardous Substances Data: 956317-36-5(Hazardous Substances Data)

Upstream product

• 52548-14-8 2-iodoyl-5-methylbenzoic acid 
• 288-36-8 1 ,2,3-Triazole 
• 288-36-8 1,2,3-triazole 
• 6967-82-4 2-bromo-5-methylbenzoic acid 
• 103755-53-9 2-(4-methylphenyl)-2H-[1,2,3]-triazole 
• 106-38-7 para-bromotoluene 
• 79762-67-7 glyoxal-bis-p-tolylhydrazone 
• 124-38-9 carbon dioxide 
• 64113-84-4 2-fluoro-5-methylbenzonitrile 
• 1381980-75-1 2-(2-iodo-4-methylphenyl)-2H-[1,2,3]triazole 
• 103440-52-4 methyl 2-iodo-5-methylbenzoate 

Downstream Products

• 1001401-58-6 allyl 5-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepane-1-carboxylate 
• 1001401-68-8 tert-butyl 3-methyl-4-(5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-1,4-diazepane-1-carboxylate 
• 1030377-31-1 benzyl (5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)-benzoyl]-1,4-diazepane-1-carboxylate 
• 1104546-96-4 5-methyl-2-(2Η-1,2,3-triazol-2-yl)benzoyl chloride 
• 1088991-70-1 5-fluoro-2-(((3R,6R)-6-methyl-1-(5-methyl-2-(2H-1,2,3-triazol-2-yl)-benzoyl)-piperidin-3-yl)-methoxy)-pyridine 
• 1149352-48-6 tert-butyl 6,7-dimethyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane-1-carboxylate 
• 1149352-54-4 2-{5,6-dimethyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}-6-fluoroquinazoline 
• 1224433-87-7 {5-methyl-1-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]pyrrolidin-3-yl}methanol 
• 1224373-97-0 3-[(4-fluoro-3-methylphenoxy)methyl]-1-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]azepane 
• 1224373-98-1 6-[(4-fluoro-3-methylphenoxy)methyl]-2-methyl-1-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]azepane 
• 1224374-11-1 6-[(4-fluoro-3-methylphenoxy)methyl]-3-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl] - 1 ,4-oxazepane 
• 1241052-33-4 C₂₅H₂₄FN₇O 
• 1001856-75-2 C₂₁H₂₇N₅O₃ 

Relevant articles and documents

Monoacylglycerol Lipase Modulators

Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.

A method of preparing intermediates of su wolei lives (by machine translation)

The invention discloses a method for the preparation of su wolei lives, comprises the following steps: to trace cuprous iodide as a catalyst, in order to water-free potassium carbonate as the alkali and three types of solvent acetone as solvent, 2 - iodo - 5 methyl benzoic acid and 1, 2, 3 - triazole generating Ullman reaction, after an ethanol and water mixed solvent can be refined to obtain high-purity of intermediates su wolei lives. Preparation method of the invention, make full use of the atom economic theory, easy operation, low cost, pollution-free. For large scale industrial production; and by only one refining, chromatographic purity can be up to 99.8% or more, isomer is less than 0.1%, the yield is 90% or more. (by machine translation)

SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

There is provided a compound of formula (I), wherein L1 to L3, R1 to R4, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.